Controversy over cervical cancer vaccine spurs safety surveillance.
Keim
Brandon
B
D005260:Female; D006801:Humans; D053918:Papillomavirus Vaccines; D011358:Product Surveillance, Postmarketing; D018570:Risk Assessment; D014481:United States; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control* / Q000821:virology
D053918:Papillomavirus Vaccines